These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 4589131)

  • 1. Interconversion of type C and D strains of Clostridium botulinum by specific bacteriophages.
    Eklund MW; Poysky FT
    Appl Microbiol; 1974 Jan; 27(1):251-8. PubMed ID: 4589131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observations on bacteriophages of Clostridium botulinum type C isolates from different sources and the role of certain phages in toxigenicity.
    Hariharan H; Mitchell WR
    Appl Environ Microbiol; 1976 Jul; 32(1):145-58. PubMed ID: 61735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of bacteriophages to alpha toxin production in Clostridium novyi types A and B.
    Eklund MW; Poysky FT; Peterson ME; Meyers JA
    Infect Immun; 1976 Sep; 14(3):793-803. PubMed ID: 965096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phage conversion to hemagglutinin production in Clostridium botulinum types C and D.
    Oguma K; Iida H; Shiozaki M
    Infect Immun; 1976 Sep; 14(3):597-602. PubMed ID: 786888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of a toxic component of Clostridium botulinum types C and D by trypsin.
    Eklund MW; Poysky FT
    Appl Microbiol; 1972 Jul; 24(1):108-13. PubMed ID: 4560464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High and low toxin production by a non-toxigenic strain of Clostridium botulinum type C following infection with type C phages of different passage history.
    Oguma K; Iida H
    J Gen Microbiol; 1979 May; 112(1):203-6. PubMed ID: 383896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfer of neurotoxigenicity from Clostridium butyricum to a nontoxigenic Clostridium botulinum type E-like strain.
    Zhou Y; Sugiyama H; Johnson EA
    Appl Environ Microbiol; 1993 Nov; 59(11):3825-31. PubMed ID: 8285687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interspecies conversion of Clostridium botulinum type C to Clostridium novyi type A by bacteriophage.
    Eklund MW; Poysky FT; Meyers JA; Pelroy GA
    Science; 1974 Nov; 186(4162):456-8. PubMed ID: 4606682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of two inducible bacteriophages, alpha 1 and alpha 2, isolated from Clostridium botulinum type A 190L and their deoxyribonucleic acids.
    Kinouchi T; Takumi K; Kawata T
    Microbiol Immunol; 1981; 25(9):915-27. PubMed ID: 6273702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The stability of toxigenicity in Clostridium botulinum types C and D.
    Oguma K
    J Gen Microbiol; 1976 Jan; 92(1):67-75. PubMed ID: 1107486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observations on nonconverting phage, c-n71, obtained from a nontoxigenic strain of Clostridium botulinum type C.
    Oguma K; Iida H; Inoue K
    Jpn J Microbiol; 1975 Jun; 19(3):167-72. PubMed ID: 1100888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phage conversion of Clostridium novyi type A (author's transl)].
    Schallehn G; Eklund MW; Brandis H
    Zentralbl Bakteriol A; 1980 Jun; 247(1):95-100. PubMed ID: 7434996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homogeneity and heterogeneity of toxins produced by Clostridium botulinum type C and D strains.
    Oguma K; Syuto B; Agui T; Iida H; Kubo S
    Infect Immun; 1981 Nov; 34(2):382-8. PubMed ID: 6171518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of bacteriophage nucleic acids obtained from Clostridium botulinum types C and D.
    Fujii N; Oguma K; Yokosawa N; Kimura K; Tsuzuki K
    Appl Environ Microbiol; 1988 Jan; 54(1):69-73. PubMed ID: 3278690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteriophage and the toxigenicity of Clostridium botulinum type C.
    Eklund MW; Poysky FT; Reed SM; Smith CA
    Science; 1971 Apr; 172(3982):480-2. PubMed ID: 4927679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenicity of converting phages obtained from Clostridium botulinum types C and D.
    Oguma K; Iida H; Shiozaki M; Inoue K
    Infect Immun; 1976 Mar; 13(3):855-60. PubMed ID: 773828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of converting and non-converting phages, harbored in the strains of Clostridium botulinum types C and D isolated in Japan.
    Sunagawa H; Inoue K
    J Vet Med Sci; 1991 Oct; 53(5):951-4. PubMed ID: 1836387
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of toxins of Clostridium butyricum and Clostridium botulinum type E.
    Giménez JA; Sugiyama H
    Infect Immun; 1988 Apr; 56(4):926-9. PubMed ID: 3126148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competitive inhibition between different Clostridium botulinum types and strains.
    Eklund MW; Poysky FT; Peterson ME; Paranjpye RN; Pelroy GA
    J Food Prot; 2004 Dec; 67(12):2682-7. PubMed ID: 15633672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomics of Clostridium botulinum group III strains.
    Sakaguchi Y; Suzuki T; Yamamoto Y; Nishikawa A; Oguma K
    Res Microbiol; 2015 May; 166(4):318-25. PubMed ID: 25111022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.